According to the Sepsis-3 criteria, sepsis was more prevalent among patients using 0–15 mg glucocorticoids per day (64.6–68.4%) and patients using IMPD inhibitors (61.8%) as compared to the whole cohort (53.1%, Table S2, appendix). Here, IMPDH1 is linked to Sepsis.